Daily coverage of equity markets, sectors, and major indices.
In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.
23,137 total articles
Morgan Stanley lowered its rating on Cleveland-Cliffs to Equal-weight from Overweight, saying the supply-driven surge in U.S. hot-rolled coil prices appears to be approaching a turning point. The bank raised short-term price forecasts after HRC climbed to roughly $1,140 per short ton, but predicts increased domestic output and higher imports will p…
Space Exploration Technologies Corp. (Nasdaq: SPCX) has announced its first-ever offering of senior unsecured notes, following the receipt of BBB-tier investment-grade ratings from all three major credit rating agencies. Reported market chatter points to a potential $20 billion size for the deal, though final terms remain subject to market conditio…
Chevron has agreed to supply natural-gas-fired power to a Microsoft data center in Reeves County, Texas, under a 20-year arrangement tied to Project Kilby. The site is planned to consume nearly 2.7 gigawatts of electricity across more than 2,000 acres, with turbines from GE Vernova and Caterpillar and a buildout timeline that targets initial power …
Taysha Gene Therapies Inc saw its stock move higher in premarket trading after the company said it has finished dosing patients in the pivotal REVEAL trial for TSHA-102, a candidate for Rett syndrome. The firm disclosed longer-term clinical outcomes showing accumulating functional gains and reported no treatment-related serious adverse events throu…
BitFuFu Inc. (NASDAQ: FUFU) said its board authorized a share repurchase program allowing up to $5 million of Class A ordinary shares to be bought over a 24-month period beginning June 24, 2026. The announcement coincided with an 8.2% gain in pre-market trading. Management said repurchases will be funded from existing cash and cash equivalents and …
Nuvectis Pharma saw its stock climb in premarket trading after announcing an exclusive ex-China licensing agreement with Haisco Pharmaceutical Group covering two clinical-stage compounds. The arrangement brings NXP100, a Complement Factor B inhibitor with late-stage data in multiple complement-mediated diseases, and NXP200, an oral brain-penetrant …
Regenxbio said the U.S. Food and Drug Administration has indicated it will reverse a prior decision declining approval of Navsunli, the company’s gene therapy for Hunter syndrome, and that the data already on file could support an accelerated approval application. The company reported a premarket share rise of about 10% following the agency’s signa…
Adobe projects the 12th annual Prime Day will prompt $26.3 billion in online purchases across Amazon and competing retailers over a four-day span, a 9% rise from last year. Walmart and Target will stage simultaneous promotions, while research and market estimates point to strong Prime membership penetration and a large share of U.S. online spending…
Chevron shares climbed in pre-market trading following the announcement of a 20-year power purchase agreement with Microsoft to supply natural-gas-fired electricity to a proposed, large-scale data center campus in West Texas. Market participants highlighted the deal's cash flow profile - explicitly structured to be insulated from oil and gas price …
Amazon’s Prime Day, moved up to June 23-26, will spotlight whether U.S. consumer spending remains resilient or shows strain. The retailer is emphasizing perishables, household basics and back-to-school items, while promoting an AI shopping assistant and preparing for intense competition from Walmart and Target. Analysts and lenders say shoppers are…
Palvella Therapeutics Inc saw its stock climb in premarket trading after the U.S. Food and Drug Administration accepted a rolling review of the company's New Drug Application for QTORIN rapamycin, an investigational therapy for microcystic lymphatic malformations. The rolling review allows incremental submission of completed NDA sections while the …
Bank of America analysts argue that gold mining stocks are undervalued relative to the current price of bullion. Despite recent declines in the metal driven by a stronger dollar and a more hawkish Federal Reserve posture, BofA’s valuation work suggests shares are pricing gold at a meaningful discount to spot. Central bank demand and longer-term str…
Shares of Praxis Precision Medicines rose after the U.S. Food and Drug Administration granted Breakthrough Therapy Designation to elsunersen for treating seizures tied to SCN2A Developmental and Epileptic Encephalopathy. The designation was based on positive Phase 1/2 EMBRAVE Part A data showing a 77% sham-adjusted reduction in monthly seizures and…
Cleveland-Cliffs Inc. (CLF) fell in premarket trading after Morgan Stanley lowered its rating on the stock from Overweight to Equalweight even as the firm raised its steel price outlook. The analyst maintained a $12.50 price target and said much of the upside from high hot-rolled coil prices is already baked into equities, while noting potential up…
ECARX Holdings announced a definitive agreement to acquire the entire Flyme software portfolio for RMB 1.8 billion (about $266 million). The deal transfers 100% of equity in a newly carved-out entity that holds Flyme Auto and Flyme OS, with financing expected to be roughly 70% syndicated 10-year bank loans and 30% internal funding. Management accou…
Fervo Energy said it has partnered with Nvidia and the Pacific Northwest National Laboratory to develop EGS-Twin, a digital twin platform for enhanced geothermal systems. The announcement sent Fervo shares up 11.1% in premarket trading Monday. The initiative will use Fervo’s Nevada and Utah field data, Nvidia AI infrastructure and PNNL high-perform…
On June 22 Sinda kicked off its U.S. initial public offering roadshow, seeking a valuation of up to $1.97 billion. The Electrum Group-backed exploration firm is proposing to sell 17.75 million shares at $11.25 to $13.25 each, potentially raising as much as $235.2 million. The offering arrives amid a pickup in new listings, with other companies laun…
AbbVie’s $10.9 billion acquisition of Apogee Therapeutics continues a recent wave of large-scale deals by U.S.-based pharmaceutical and biotechnology firms. Over the past decade, companies have pursued assets across immunology, oncology, neurology, rare diseases, obesity treatments and diagnostics. The list below compiles major transactions reporte…
ITG, a Hendersonville, Tennessee-based digital infrastructure firm owned by Oaktree Capital Management, has filed to list on Nasdaq under the symbol ITG, targeting a valuation of as much as $2.67 billion. The company plans to raise up to $429.3 million by selling 19.5 million shares at $19 to $22 each as part of an active post-SpaceX IPO market. IT…
JPMorgan says battered consumer cyclicals may be forming a bottom and could outperform in the second half of 2026. Analyst Mislav Matejka points to multi-year low price relatives, undemanding valuations and depressed consumer confidence, and highlights catalysts including lower oil prices, reduced tariff rates and the potential for a U.S. consumer …
Ligand Pharmaceuticals shares fell in pre-market trading following the firm's disclosure of a private placement of $550 million in convertible senior notes due September 2031, with an underwriter option for an additional $82.5 million. The debt issuance, structured as a Rule 144A offering to qualified institutional buyers, raises both leverage and …
ITG, a Tennessee-based provider of outsourced digital infrastructure services, filed to list on the Nasdaq and aims to raise up to $429.3 million by offering 19.5 million Class A common shares at a $19 to $22 price range. At the top of that range, the offering would imply a $2.67 billion valuation. The company and a selling stockholder are providin…
Definium Therapeutics' stock climbed sharply in pre-market trading after the company reported that its Phase 3 Emerge trial for DT120 ODT met the study's primary endpoint in major depressive disorder, showing an 8.1-point placebo-adjusted improvement on the Montgomery-Åsberg Depression Rating Scale at Week 6. Shares rose 38.9% to $34.01 pre-open as…
Credo Technology shares jumped in pre-market trading after Evercore ISI launched coverage with an Outperform rating and a $325 price target, the most bullish call on the street. The firm highlighted Credo’s potential transition from a copper-centric AI connectivity supplier toward a combined copper and optical solutions platform, forecasting rapid …
BofA Securities highlights two European industrial names as preferred ideas amid muted industrial production and margin pressures. The broker argues current valuations imply a cancellation of recovery rather than a temporary delay, recommending KION Group and Jungheinrich as buys on the view that both stocks trade at depressed multiples despite exp…
